This is an open-label, expanded access protocol, designed to offer treatment with SAGE-547 to subjects in SRSE, and to evaluate the efficacy and safety of SAGE-547 administered as a continuous intravenous infusion to these subjects
Study Type
EXPANDED_ACCESS
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.